Biocon, with Rs.1,000 crore consolidated revenue, is now India's largest biotech company, focussed on delivering affordable innovation. It works towards reducing therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases by leveraging India's cost advantage to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe.